Regulatory: Page 10

CMS releases proposed Medicare Physician Fee Schedule for 2023
By Brian Casey
The U.S. Centers for Medicare and Medicaid Services (CMS) on July 7 issued its proposed Medicare Physician Fee Schedule for 2023. Simultaneously, CMS postponed the start of the penalty phase for its mandate on using appropriate use criteria/clinical decision support for advanced imaging studies.
July 7, 2022
2020 08 20 21 51 4342 Doctor Tablet Consult Closeup 400
How to enhance practice revenue using video reporting
By Erin Stephens
Video reporting can enhance a radiology practice's revenue when it is appropriate for providing consultative reports to ordering physicians. But how do you get paid for it? Erin Stephens of Healthcare Administrative Partners explains.
July 6, 2022
2022 07 06 17 35 0405 Computer Doctor Patient Video 400
CMS rejects ACR request to cover CT colonography screening
By AuntMinnie.com staff writers
The U.S. Centers for Medicare and Medicaid Services (CMS) has rejected a request from the American College of Radiology (ACR) to expand Medicare coverage for screening CT colonography for colorectal cancer.
July 5, 2022
2021 10 04 18 46 2240 Colorectal Cancer 400
FDA yanks MQSA certificate from imaging facility in Md.
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has revoked the certification under the Mammography Quality Standards Act (MQSA) of a mammography facility in Maryland that has a history of problems with image quality.
June 30, 2022
2019 02 13 19 24 5396 Fda Logo V2 400
Seno secures supplemental PMA for Imagio
By AuntMinnie.com staff writers
Optoacoustic imaging firm Seno Medical Instruments has received supplemental premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) for its Imagio breast imaging system.
June 27, 2022
2021 04 29 18 14 4885 Breast Cancer 3 D 400
Biden creates new cancer care model for Medicare patients
By AuntMinnie.com staff writers
The Biden administration has announced the Enhancing Oncology Model (EOM), a new model to improve cancer care among Medicare patients and address health equity.
June 26, 2022
2020 02 27 23 28 4046 Doctor Cancer Patient 400
CMS rethinks limit on PET scans for Alzheimer’s disease patients
By Will Morton
The U.S. Centers for Medicare and Medicaid Services (CMS) will take another look at its recent national coverage determination that limits Alzheimer’s disease patients eligible for monoclonal antibody treatments to a single PET scan.
June 26, 2022
2017 05 04 10 02 04 942 Capitol Hill2 400
U.S. report on COVID response says Atlas strategy caused deaths
By Brian Casey
A new report issued by a U.S. House of Representatives subcommittee on the Trump administration's response to the COVID-19 pandemic blames controversial neuroradiologist Dr. Scott Atlas for a strategy that led to thousands of "preventable" deaths from the SARS-CoV-2 virus.
June 21, 2022
2020 07 01 22 14 2802 Washington Dc Capitol 400
FDA finalizes quantitative imaging guidance
By AuntMinnie.com staff writers
Three years after the draft guidance was published, the U.S. Food and Drug Administration (FDA) has published its final guidance for manufacturers planning to submit radiological devices with quantitative imaging functionality for premarket review.
June 14, 2022
2019 02 13 19 24 5396 Fda Logo V2 400
Biden signs MAMMO Act to improve breast imaging for veterans
By Brian Casey
President Joe Biden on June 7 signed the Making Advances in Mammography and Medical Options for Veterans Act (the MAMMO Act), legislation that would improve breast imaging services for military veterans.
June 6, 2022
2022 06 07 22 45 7400 Patient Woman Veteran Wheelchair 400
Stryker nets FDA clearance for Q Guidance
By AuntMinnie.com staff writers
Orthopedic device developer Stryker has garnered U.S. Food and Drug Administration (FDA) 510(k) clearance for its Q Guidance spine surgery navigation software.
May 30, 2022
2020 02 24 17 44 7728 Clearance Stamp 400
Telix gets pass-through status for Illuccix
By AuntMinnie.com staff writers
Telix Pharmaceuticals has received transitional pass-through payment status from the U.S. Centers for Medicare and Medicaid Services for its Illuccix prostate-specific membrane antigen PET radiopharmaceutical.
May 30, 2022
2019 04 17 20 48 2514 Prostate 3 D 400
Previous Page
Page 10 of 304
Next Page